Multiple myeloma, also known as myeloma, is a hematologic cancer (or cancer of the blood). Although multiple myeloma is the second most common blood cancer, after non-Hodgkin lymphoma, it is not a common cancer. The American Cancer Society estimates that 30,770 new cases of multiple myeloma will be diagnosed in 2018. Multiple myeloma is more common in men than women, and it occurs more frequently with increasing age, with the greatest incidence in those over age 70.
The main goal of this project is to raise awareness about provider education needs related to this patient population; to establish vetted, designated resources to help fill unmet needs; to help educate the cancer care team on effective practices in caring for patients with multiple myeloma; and to foster a network of engaged community cancer care professionals.
Specifically, this project is delivering:
Host a live, full-day Visiting Experts Workshop at your institution on the key issues related to the support, treatment, and management of patients diagnosed with multiple myeloma. Selected sites will receive a $5,000 stipend for their participation. If you are interested in hosting a Visiting Experts Workshop at your cancer program or practice, please contact Limaya Atembina, MSW, Program Manager, ACCC Provider Education, or click here to learn more.
Multidisciplinary Multiple Myeloma Care: Models of Effective Care Delivery offers a convenient summary of recent updates in the management of this heterogeneous disease, including information on:
Plus, read how three cancer programs—a community-based comprehensive program, an academic medical center, and an NCI-designated program—are delivering multidisciplinary care to this patient population.
ACCC thanks the following member programs for their participation:
Funding & support provided by Amgen Oncology